177Lu-PSMA
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for 177Lu-PSMA, covering 2023-12-15 to 2026-02-24. Get the full timeline:
Most recent: Clinical Trial Update: 177LuPSMA in Renal Cell Carcinoma [Phase 2]